Xcout Intel
Dren Bio, Inc.
Dren Bio, Inc. is a biotechnology company headquartered in San Carlos, California, focused on developing powerful protein-engineering technologies.
Subscribe to see Dren Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Dren Bio, Inc. at a glance
Dren Bio, Inc. is a biopharmaceuticals company headquartered in United States. Its most recent funding round raised $25M in July 2024. Xcout tracks 14 named people at Dren Bio, Inc., including Amit Mehta (Chief Operating Officer and Chief Business Officer).
Dren Bio, Inc. leadership
- Amit MehtaChief Operating Officer and Chief Business Officer
- Nenad TomasevicChief Executive Officer, Founder
- Jeff MacfarlandExecutive Vice President, Finance
- Sridhar ViswanathanExecutive Vice President, Process Sciences and Manufacturing Operations
- Benjamin KozubSenior Vice President, Head of Commercial
- Shalini GidwaniSenior Vice President, Regulatory Affairs
8 more named people on record for Dren Bio, Inc., with roles, board committees and tenure — see the full roster →
Dren Bio, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $25M | — | |
| Series B | $65M | 2 named | |
| Series A | $60M | 2 named | |
| SEC Form D filing | $25.5M | — | |
| SEC Form D filing | $5.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Dren Bio, Inc. competitors
A few of Dren Bio, Inc.'s closest competitors — see the full list of competitors and alternatives →
Amunix Pharmaceuticals, Inc. is a biopharmaceutical company located in South San Francisco and Mountain View, California. The company focuses on oncology, leveraging its proprietary Pro-XTEN technology platform to engineer novel protein therapeutics.
Mendra is a venture-backed biotechnology research startup established in 2025 and headquartered in San Francisco, focused on accelerating the development and commercialization of rare disease therapies.
Dermira, Inc. is a biotechnology company focused on medical dermatology, with its main headquarters located in Menlo Park, California, United States.
Retrotope, Inc. is a drug development company headquartered in Los Altos, California, focused on creating therapeutics for degenerative diseases.
Altay Therapeutics, Inc. is a biotechnology company founded in 2019 and headquartered in the San Francisco Bay Area, California. The company focuses on developing therapeutics within the biotechnology sector.
Get Dren Bio, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Dren Bio, Inc. in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access